

Is Paxlovid still in shortage in 2026? Get the latest update on availability, cost, and what patients can do to find this COVID-19 antiviral.
If you've tried to fill a Paxlovid prescription recently and hit a wall, you're probably wondering: is there a shortage? The answer is more nuanced than a simple yes or no — and understanding the full picture can help you get the treatment you need.
Here's what patients need to know about Paxlovid availability, cost, and access in 2026.
As of early 2026, Paxlovid is not listed on the FDA's official drug shortage list. That means, on a national level, supply exists. Pfizer continues to manufacture and distribute the medication.
However, that doesn't mean every pharmacy has it. The reality on the ground is more complicated:
So while it's not a formal shortage in the FDA sense, it can certainly feel like one when you're the patient trying to find it.
Several factors contribute to the availability challenges:
At $1,400 to $1,600 per 5-day course, Paxlovid is one of the most expensive medications a pharmacy can keep on its shelves. If it expires before being dispensed, that's a significant financial loss. Many pharmacies — especially smaller ones — simply don't take that risk.
There is no generic version of Paxlovid available in the US as of early 2026. Without generic alternatives driving down costs and increasing supply, the market remains constrained to what Pfizer produces and distributes.
COVID-19 continues to circulate with seasonal patterns. Winter surges can overwhelm local pharmacy stock within days. Since Paxlovid must be started within 5 days of symptoms, this creates a time-sensitive problem that standard pharmacy ordering cycles can't always keep up with.
The U.S. government stopped purchasing and distributing Paxlovid for free after the public health emergency ended in May 2023. The transition to commercial distribution created gaps in the supply chain that have been slow to fully resolve.
For a deeper look at all the factors: Why Is Paxlovid 5-Day So Hard to Find?
Here's what you can expect to pay:
If cost is a concern, Pfizer's PAXCESS Patient Support Program can help. Insured patients may pay as little as $0 (maximum savings of $1,500 per prescription), and uninsured patients may qualify for the medication at no cost. Visit paxlovid.com/paxcess or call 1-877-219-7225.
For detailed cost-saving strategies: How to Save Money on Paxlovid 5-Day.
The COVID-19 treatment landscape continues to evolve:
For a full comparison of alternatives: Alternatives to Paxlovid 5-Day.
If you need Paxlovid today, here's your action plan:
For a full guide with more tips: How to Find Paxlovid 5-Day in Stock Near You.
Paxlovid isn't in a formal shortage, but real-world availability remains inconsistent in 2026. The combination of high cost, no generic alternative, and seasonal demand spikes means patients sometimes struggle to find it when they need it most.
The best thing you can do is act fast. Start searching as soon as you get your prescription, use tools like Medfinder to check stock in real time, and know your cost-saving options. With the right approach, most patients can still access Paxlovid within the critical treatment window.
Learn more about the medication itself: What Is Paxlovid 5-Day? Uses, Dosage, and What You Need to Know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.